NCT07246863 2026-04-21
Trial Investigating Visugromab and Nivolumab With or Without Docetaxel in 2L Treatment of Participants With Metastatic NSCLC
CatalYm GmbH
Phase 2 Recruiting
CatalYm GmbH
Kaiser Permanente
The Canadian College of Naturopathic Medicine
Brigham and Women's Hospital
Korea University Guro Hospital
First Affiliated Hospital of Kunming Medical University
Peking University First Hospital